Is %<b>Δ</b>SUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer?

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Number of patients</td><td align="center">86</td></tr><tr><td align="left">Sex</td><td align="center">67 M<br/>19 F</td></tr><tr><td align="left">Mean age</td><td align="center">
								63.5 y (range: 37–80)</td></tr><tr><td align="left">Histotypes</td><td align="center"> </td></tr><tr><td align="left"> Adenocarcinoma</td><td align="center">41</td></tr><tr><td align="left"> Squamous</td><td align="center">16</td></tr><tr><td align="left"> Large cell</td><td align="center">9</td></tr><tr><td align="left"> Others    </td><td align="center">20</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>
							M: male; F: female; y: years.<br/></td></tr></table>

The Scientific World Journal

tab1

Table 1

Table 1: Is %<b>Δ</b>SUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer? 

The Scientific World Journal

Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer?

Table 1